Nkarta Inc. Gains 140.93%

Mon, Apr 25, 2022 at 05:30 PM

Nkarta Inc. (NKTX:NASDAQ) shot up at $18.72, representing a gain of 140.9%. On Fri, Apr 22, 2022, NKTX:NASDAQ hit a New 2-Week Low of $7.77. The stock appeared on our News Catalysts scanner on Mon, Apr 25, 2022 at 04:38 PM in the 'BIOTECH' category. From Mon, Apr 11, 2022, the stock recorded 25.00% Up Days and 22.22% Green Days

About Nkarta Inc. (NKTX:NASDAQ)

Nkarta Inc is a biopharmaceutical company developing engineered natural killer (NK) cells to fight cancer.

Top 10 Gainers:

Nkarta Inc. (NKTX:NASDAQ), 140.93%
ION Geophysical Corporation (IO:NYSE), 46.29%
Cango Inc. (CANG:NYSE), 40.68%
Rubius Therapeutics, Inc. (RUBY:NASDAQ), 40.6%
ERYTECH Pharma S.A. (ERYP:NASDAQ), 37.7%
Redbox Entertainment Inc. (RDBX:NASDAQ), 37.54%
Ardelyx, Inc. (ARDX:NASDAQ), 31.77%
GWG Holdings, Inc. (GWGH:NASDAQ), 31.14%
ImmuCell Corporation (ICCC:NASDAQ), 29.04%
Veru Inc. (VERU:NASDAQ), 25.78%